Wikipedia -WSS

Wikipedia

author：entertainment 2025-08-12 09:10:55 - browse：69693

An AstraZeneca sign at ESMO in Madrid. — An AstraZeneca ad at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Questions about one of AstraZeneca’s key cancer drug candidates — and the dribs and drabs that have come out about its performance — have been dogging the company for months.

On Monday, data presented here from a trial of the drug in advanced non-small cell lung cancer provided at least a fuller look. While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

The trial, detailed here in a prime session at the annual meeting of the European Society for Medical Oncology, is testing a therapy called datopotamab deruxtecan, or Dato-DXd, in advanced or metastatic non-small cell lung cancer in patients who already tried at least first-line treatments. Patients were randomized to either receive chemotherapy or Dato-DXd, which AstraZeneca is developing with Daiichi Sankyo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： New weight loss drugs vying to be the next Wegovy or Mounjaro

WSS

ChatGPT in medicine: STAT answers readers' burning questions

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Drug repurposing or repositioning? The language matters

Anesthesiologist group: stop taking Ozempic before surgery

A common UTI test for kids haunts adults as a traumatic 'nightmare'

A common UTI test for kids haunts adults as a traumatic 'nightmare'

leisure time

Wikipedia

leisure time

Apple is now the first public company to be valued at $3 trillion

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

FDA approval of Sarepta Duchenne genetic therapy gives me hope

WATCH: Why do bright lights make us see spots?

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Jerome Adams on the need for new antivirals for Covid

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA approval of Sarepta Duchenne genetic therapy gives me hope

knowledge

How to make the FDA’s new prescription one

FDA approves updated Covid vaccines

In Memoriam: Notable people who died in 2023

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

White House touts steps to stem shortages of cancer treatments

Medicare proposal to cover medical devices draws a mixed reaction

explore

explore

knowledge

leisure time